Screening for diabetes in patients on long-term glucocorticoid therapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients who are undergoing long-term glucocorticoid therapy, which is commonly prescribed for various inflammatory and autoimmune conditions. The study aims to assess the incidence of corticosteroid-induced diabetes in non-diabetic patients receiving glucocorticoids for more than three months. Blood samples will be collected to monitor glucose levels and evaluate the potential development of diabetes due to glucocorticoid treatment. The findings could help in identifying at-risk patients and improving management strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Person who has orally provided voluntary informed consent.
* Patient with an indication for prolonged corticosteroid therapy (more than three months)
* Non-diabetic patient

Exclusion Criteria:

* Person not affiliated to or not benefiting from national health insurance system
* Person subject to legal protection (guardianship, curatorship)
* Pregnant or breastfeeding woman
* Adult unable to provide consent
* Minor
* Evidence of fasting venous blood glucose greater than 1.26 g/L, or Glycated haemoglobin greater than 6.5% at the time of initial blood sampling before glucocorticoid treatment.
* Patient who had received corticosteroid therapy within 3 months prior to the study
* Patient with hemoglobin less than 10 g/dL

Where it's running

• CHU Dijon Bourgogne
  Dijon, France Recruiting

Study contacts

• Study coordinator: Benjamin BOUILLET
• Email: benjamin.bouillet@chu-dijon.fr
• Phone: 03.80.29.34.53

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• New virtual care pathway for older adults with chronic diseases

  A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.

  Recruiting National University of Malaysia · Kuala Lumpur · NCT07843238

• Benefits of Retained Insulin for Good Health in Diabetes

  This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.

  Recruiting at 4 sites Royal Devon and Exeter NHS Foundation Trust · Truro, Cornwall and 3 other locations · NCT07828626

• Improving Care for underserved older Black patients with cardiovascular and other chronic conditions

  This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07748858

• Myokines in metabolic and endocrine diseases linked to sarcopenia

  This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.

  Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe · NCT07703683

• Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes

  A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.

  Recruiting Indiana University · Indianapolis, Indiana · NCT07696273

• Polypill Approach for Multiple Cardiovascular Risk Factors

  Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.

  Recruiting at 5 sites China Medical University, China · Zhengzhou, Henan and 14 other locations · NCT07679828

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.